U.S.: Settlement Reached on Washington State Medicaid Denial of Pricey Hep C Drugs

The Health Care Authority on Monday reached a settlement agreement in a class action lawsuit that sought broader coverage of costly hepatitis C drugs for Medicaid patients in Washington state. The settlement has yet to be approved by a judge but lawyers are hopeful it will be soon. In the past several years, multiple pharmaceutical companies nationwide have developed direct-acting antiviral drugs that cure hepatitis C in more than 90 percent of patient

US: Judge allows public employees access to pricey hepatitis C drugs

Members of the Washington’s Public Employees Benefits Board infected with hepatitis C will be able to receive expensive drugs that can cure the life-threatening disease, a judge ruled Wednesday. A King County Superior Court judge has ordered the agency that oversees health insurance for Washington’s public employees to pay for expensive drugs to treat hepatitis C in all patients, not just those with the most severe illness. Judge Suzanne R. Parisien gr

Washington state told to lift restrictions on hepatitis C medicines

The Washington state Medicaid program has been ordered to lift restrictions on coverage of pricey hepatitis C treatments, according to a preliminary injunction issued Friday by a federal judge in Seattle. The ruling came in response to a lawsuit filed by state residents who claim the drugs are “medically necessary,” and that the decision by the Washington State Health Care Authority to provide coverage to only the sickest patients had caused them harm. I

State official: Hepatitis C flying under the radar but numbers rising

PORT ANGELES — A deadly liver disease is being ignored despite its growing prevalence, a state epidemiologist told the Clallam County Board of Health last week. Hepatitis C is on the rise on the North Olympic Peninsula and other regions across the country, said Dr. Scott Lindquist, state epidemiologist for communicable diseases with the state Department of Health. “I don’t know of any other infectious disease that we ignore so completely as hepatitis C